Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial glycolytic and fermentative enzymes represent a group of metabolic proteins found in acidogenic oral bacteria, most notably Streptococcus mutans and Lactobacillus species. These enzymes, including enolase, lactate dehydrogenase (LDH), and pyruvate kinase, are responsible for the breakdown of dietary sugars into organic acids, primarily lactic acid (Takahashi & Nyvad, 2011). This metabolic process occurs within the dental plaque biofilm and is the primary driver of dental caries, as the resulting acid lowers the local pH and demineralizes tooth enamel (Marquis, 1995). Therapeutic strategies targeting these enzymes aim to disrupt the acidogenic potential of the biofilm. For example, fluoride ions directly inhibit enolase, a key glycolytic enzyme, by forming a complex with magnesium at the active site (Guha-Chowdhury et al., 1997). Additionally, sugar alcohols like xylitol act as competitive inhibitors of the phosphotransferase system (PTS), leading to a futile cycle that exhausts bacterial energy and reduces acid production (Nayak et al., 2014). Targeting these metabolic pathways is a cornerstone of preventive dentistry and oral health maintenance.
Direct inhibition of key glycolytic enzymes such as enolase and lactate dehydrogenase, or competitive interference with sugar transport systems like the phosphotransferase system (PTS) to reduce acidogenic output.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial glycolytic and fermentative enzymes of dental plaque.